Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indraprastha Medical's quarterly market cap
increased
from Sep. 2025 (₹40,794 Mil) to Dec. 2025 (₹41,047 Mil) but then
declined
from Dec. 2025 (₹41,047 Mil) to Mar. 2026 (₹34,070 Mil).
Indraprastha Medical's annual market cap
increased
from Mar. 2024 (₹15,745 Mil) to Mar. 2025 (₹35,390 Mil) but then
declined
from Mar. 2025 (₹35,390 Mil) to Mar. 2026 (₹34,070 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Indraprastha Medical's Enterprise Value for Today is ₹32,183 Mil.
Indraprastha Medical (BOM:532150) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Indraprastha Medical Market Cap Related Terms
Indraprastha Medical Market Cap Historical Data
* Premium members only.
The historical data trend for Indraprastha Medical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:532150 vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, Indraprastha Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indraprastha Medical Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's Market Cap distribution charts can be found below:
* The bar in red indicates where Indraprastha Medical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Indraprastha Medical's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indraprastha Medical (BOM:532150) has a Market Cap of ₹34,556 Mil as of Aug. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Indraprastha Medical and its competitors. According to the industry distribution chart, Indraprastha Medical ranks #230 out of 691 companies in the Healthcare Providers & Services industry, placing it in the top 33.3%.
Is Indraprastha Medical's Market Cap too high?
Indraprastha Medical's current Market Cap is ₹34,556 Mil. Based on the distribution chart, Indraprastha Medical ranks #230 out of 691 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Indraprastha Medical has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indraprastha Medical's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Indraprastha Medical ranks #230 out of 691 companies for Market Cap. This puts Indraprastha Medical in the upper half of its industry. The industry median Market Cap is 104.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.85, based on 691 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Indraprastha Medical and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indraprastha Medical's current Market Cap is ₹34,556 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indraprastha Medical stock overvalued right now?
Based on GuruFocus' analysis, Indraprastha Medical (BOM:532150) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹428.14, compared to a current price of ₹376.95 — trading 12% below its estimated fair value. The current Market Cap is ₹34,556 Mil. Indraprastha Medical's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Indraprastha Medical (BOM:532150), the current Market Cap is ₹34,556 Mil as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indraprastha Medical (BOM:532150) Overvalued in 2026?
Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued.
The current stock price of ₹376.95 is trading 12% below its estimated GF Value™ of ₹428.14.
GuruFocus considers Indraprastha Medical to be Modestly Undervalued.
Key valuation signals for BOM:532150:
Market Cap: ₹34,556 Mil
GF Value™: ₹428.14 vs. price of ₹376.95 (12% below fair value)
No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
81GF Score
Get the complete analysis for BOM:532150
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532150 has been successfully added to your 
